Articles dans des revues avec comité de lecture (45)
  1. 1. Van Morckhoven, D., Dubois, N., Bron, D., Meuleman, N., Lagneaux, L., & Stamatopoulos, B. (2023). Extracellular vesicles in hematological malignancies: EV-dence for reshaping the tumoral microenvironment. Frontiers in immunology, 14, 1265969. doi:10.3389/fimmu.2023.1265969
  2. 2. Pagano, G., Botana, I. F., Wierz, M., Roessner, P., Ioannou, N., Zhou, X., Al-Hity, G., Borne, C., Gargiulo, E., Gonder, S., Qu, B., Stamatopoulos, B., Ramsay, A. G., Seiffert, M., Largeot, A., Moussay, E., & Paggetti, J. (2023). Interleukin-27 potentiates CD8+ T-cell-mediated anti-tumor immunity in chronic lymphocytic leukemia. Haematologica. doi:10.3324/haematol.2022.282474
  3. 3. Draguet, F., Dubois, N., Bouland, C., Pieters, K., Bron, D., Meuleman, N., Stamatopoulos, B., & Lagneaux, L. (2023). Extracellular Vesicles Derived from Human Umbilical Cord Mesenchymal Stromal Cells as an Efficient Nanocarrier to Deliver siRNA or Drug to Pancreatic Cancer Cells. Cancers, 15(11), 2901. doi:10.3390/cancers15112901
  4. 4. Delbart, W., Marin, G., Stamatopoulos, B., De Wind, R., Sirtaine, N., Demetter, P., Vercruyssen, M., Woff, E., Karfis, I., Ghanem, G. E., Flamen, P., & Wimana, Z. (2023). Disturbing the Redox Balance Using Buthionine Sulfoximine Radiosensitized Somatostatin Receptor-2 Expressing Pre-Clinical Models to Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE. Cancers (Basel), 15(8). doi:10.3390/cancers15082332
  5. 5. Largeot, A., Klapp, V., Viry, E., Gonder, S., Fernandez Botana, I., Blomme, A., Benzarti, M., Pierson, S., Duculty, C., Marttila, P., Wierz, M., Gargiulo, E., Pagano, G., An, N., El Hachem, N., Perez Hermandez, D., Chakraborty, S., Ysebaert, L., François, J.-H., Cortez Clemente, S. D., Berchem, G., Efremov, D., Dittmar, G., Szpakowska, M., Chevigne, A., Nazarov, P. V., Helleday, T., Close, P., Meiser, J., Stamatopoulos, B., Désaubry, L., Paggetti, J., & Moussay, E. (2023). Inhibition of MYC translation through targeting of the newly identified PHB-eIF4F complex as therapeutic strategy in CLL. Blood. doi:10.1182/blood.2022017839
  6. 6. Draguet, F., Bouland, C., Dubois, N., Bron, D., Meuleman, N., Stamatopoulos, B., & Lagneaux, L. (2023). Potential of Mesenchymal Stromal Cell-Derived Extracellular Vesicles as Natural Nanocarriers: Concise Review. Pharmaceutics, 15(2). doi:10.3390/pharmaceutics15020558
  7. 7. Cia Beriain, G., Kwasigroch, J.-M., Stamatopoulos, B., Rooman, M., & Pucci, F. (2023). pyScoMotif: discovery of similar 3D structural motifs across proteins. Bioinformatics Advances, 3(1). doi:10.1093/bioadv/vbad158
  8. 8. Massaro, F., Corrillon, F., Stamatopoulos, B., Dubois, N., Ruer, A., Meuleman, N., Bron, D., & Lagneaux, L. (2023). Age-related changes in human bone marrow mesenchymal stromal cells: morphology, gene expression profile, immunomodulatory activity and miRNA expression. Frontiers in immunology, 14, 1267550. doi:10.3389/fimmu.2023.1267550
  9. 9. Robbe, P., Ridout, K., Vavoulis, D. V., Dréau, H., Kinnersley, B., Denny, N., Chubb, D., Appleby, N., Cutts, A., Cornish, A. A., Lopez-Pascua, L., Clifford, R., Burns, A., Stamatopoulos, B., Cabes, M., Alsolami, R., Antoniou, P., Oates, M., Cavalieri, D., Genomics England Research Consortium,, CLL pilot consortium,, Gibson, J., Prabhu, A. A., Schwessinger, R., Jennings, D., James, T., Maheswari, U., Duran-Ferrer, M., Carninci, P., Knight, S. J. L., Månsson, R., Hughes, J., Davies, J., Ross, M., Bentley, D., Strefford, J. C., Devereux, S., Pettitt, A. R., Hillmen, P., Caulfield, M. M., Houlston, R. S., Martín-Subero, J. I., & Schuh, A. (2022). Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features. Nature genetics, 54(11), 1675-1689. doi:10.1038/s41588-022-01211-y
  10. 10. Gargiulo, E., Viry, E., Morande, P. E., Largeot, A., Gonder, S., Xian, F., Ioannou, N., Benzarti, M., Kleine Borgmann, F. B., Mittelbronn, M., Dittmar, G., Nazarov, P. P., Meiser, J., Stamatopoulos, B., Ramsay, A. A., Moussay, E., & Paggetti, J. (2022). Extracellular vesicle secretion by leukemia cells in vivo promotes CLL progression by hampering antitumor T-cell responses. Blood cancer discovery. doi:10.1158/2643-3230.BCD-22-0029
  11. 11. Klintman, J., Appleby, N., Stamatopoulos, B., Ridout, K., Eyre, T. A., Robbe, P., Pascua, L. L., Knight, S. J., Dreau, H., Cabes, M., Popitsch, N., Ehinger, M., Martín-Subero, J. I., Campo, E., Månsson, R., Rossi, D., Taylor, J. C., Vavoulis, D. D., & Schuh, A. (2021). Genomic and transcriptomic correlates of Richter transformation in chronic lymphocytic leukemia. Blood, 137(20), 2800-2816. doi:10.1182/blood.2020005650
  12. 12. Massaro, F., Corrillon, F., Stamatopoulos, B., Meuleman, N., Lagneaux, L., & Bron, D. (2021). Aging of bone marrow mesenchymal stromal cells: Hematopoiesis disturbances and potential role in the development of hematologic cancers. Cancers (Basel), 13(1), 68, 1-22. doi:10.3390/cancers13010068
    13. << Précédent 1 2 3 4 5 6 7 Suivant >>